CRISPR/Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBV.
CRISPR/Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBV.
复制标题
DOI:
10.3390/ijms22094842
复制
发表时间:
2021-05-03
影响因子:
5.6
通讯作者:
Duan G
中科院分区:
文献类型:
--
作者:
Ding R;Long J;Yuan M;Zheng X;Shen Y;Jin Y;Yang H;Li H;Chen S;Duan G
Hepatitis B remains a major global public health challenge, with particularly high prevalence in medically disadvantaged western Pacific and African regions. Although clinically available technologies for the qPCR detection of HBV are well established, research on point-of-care testing has not progressed substantially. The development of a rapid, accurate point-of-care test is essential for the prevention and control of hepatitis B in medically disadvantaged rural areas. The development of the CRISPR/Cas system in nucleic acid detection has allowed for pathogen point-of-care detection. Here, we developed a rapid and accurate point-of-care assay for HBV based on LAMP-Cas12a. It innovatively solves the problem of point-of-care testing in 10 min, particularly the problem of sample nucleic acid extraction. Based on LAMP-Cas12a, visualization of the assay results is presented by both a fluorescent readout and by lateral flow test strips. The lateral flow test strip technology can achieve results visible to the naked eye, while fluorescence readout can achieve real-time high-sensitivity detection. The fluorescent readout-based Cas12a assay can achieve HBV detection with a limit of detection of 1 copy/μL within 13 min, while the lateral flow test strip technique only takes 20 min. In the evaluation of 73 clinical samples, the sensitivity and specificity of both the fluorescence readout and lateral flow test strip method were 100%, and the results of the assay were fully comparable to qPCR. The LAMP-Cas12a-based HBV assay relies on minimal equipment to provide rapid, accurate test results and low costs, providing significant practical value for point-of-care HBV detection.
登录
查看更多内容
DOI:
10.1126/science.aas8836
发表时间:
2018-04-27
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Myhrvold C;Freije CA;Gootenberg JS;Abudayyeh OO;Metsky HC;Durbin AF;Kellner MJ;Tan AL;Paul LM;Parham LA;Garcia KF;Barnes KG;Chak B;Mondini A;Nogueira ML;Isern S;Michael SF;Lorenzana I;Yozwiak NL;MacInnis BL;Bosch I;Gehrke L;Zhang F;Sabeti PC
通讯作者:
Sabeti PC
DOI:
10.1016/s2468-1253(20)30307-1
发表时间:
2021-03
期刊:
The lancet. Gastroenterology & hepatology
影响因子:
--
作者:
Tan M;Bhadoria AS;Cui F;Tan A;Van Holten J;Easterbrook P;Ford N;Han Q;Lu Y;Bulterys M;Hutin Y
通讯作者:
Hutin Y
DOI:
10.1126/science.aav4294
发表时间:
2018-11-16
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Harrington LB;Burstein D;Chen JS;Paez-Espino D;Ma E;Witte IP;Cofsky JC;Kyrpides NC;Banfield JF;Doudna JA
通讯作者:
Doudna JA
影响因子:
33.5
作者:
Li SY;Cheng QX;Wang JM;Li XY;Zhang ZL;Gao S;Cao RB;Zhao GP;Wang J
通讯作者:
Wang J
影响因子:
168.9
作者:
Schweitzer, Aparna;Horn, Johannes;Ott, Joerdis J.
通讯作者:
Ott, Joerdis J.